C00583-2026

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

DITO CME Holdings Corp.DITO

PSE Disclosure Form 4-29 - Disbursement of Proceeds and Progress Report References: Memorandum No. 626 - 2007 dated December 20, 2007
Section 4.4 of the Revised Disclosure Rules

Subject of the Disclosure

DITO's Annual Report for the year 2025 on the Use of its Proceeds from the Follow-On Offering

Background/Description of the Disclosure

Please see attached the following on DITO's use of proceeds, as of the calendar year ended 31 December 2025, in relation to its Follow-On Offering:

1. SEC Form 17-C dated 30 January 2026;
2. CFO Certification dated 30 January 2026; and
3. External Auditor Report dated 30 January 2026.

Other Relevant Information

None.

Filed on behalf by:
Name Alyssa Hannah Nuqui
Designation Associate Legal Counsel